Literature DB >> 24649920

Prenatal developmental toxicity evaluation of Withania somnifera root extract in Wistar rats.

P C Prabu1, S Panchapakesan.   

Abstract

CONTEXT: Withania somnifera (L) Dunal (Solanaceae) is an important traditional herbal medicine used for thousands of years and is considered as the Indian ginseng. Reports on the effect of Withania somnifera root (WSR) extract on the developing foetus of pregnant rats including mortality, structural abnormalities, changes in growth and effects on dams are not available.
OBJECTIVE: The present study was performed to evaluate the prenatal developmental toxicity potential of WSR extract in rats.
MATERIALS AND METHODS: WSR extract was given orally to pregnant rats during the period of major organogenesis and histogenesis (days 5 to 19 of gestation) at the dose levels of 500, 1000 and 2000 mg/kg/day. Clinical observations including mortality, moribundity, behavioural changes, signs of overt toxicity, body weight, gross pathological changes of dams and foetal analyses including external malformations, skeletal and soft tissue malformations were evaluated.
RESULTS: No evidence of maternal or foetal toxicity was observed. WSR extract caused no changes (p < 0.05) in body weight of parental females, number of corpora lutea, implantations, viable foetuses, external, skeletal and visceral malformations. DISCUSSION AND
CONCLUSION: Under the conditions of the study, the no-observed-effect level (NOEL) of WSR extract for maternal and developmental toxicity was concluded to be at least 2000 mg/kg/day.

Entities:  

Keywords:  Alternative medicine; Indian ginseng; Siddha; ayurveda; herbal; safety; teratology

Mesh:

Substances:

Year:  2014        PMID: 24649920     DOI: 10.3109/01480545.2014.900073

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  6 in total

Review 1.  Pharmacologic overview of Withania somnifera, the Indian Ginseng.

Authors:  Nawab John Dar; Abid Hamid; Muzamil Ahmad
Journal:  Cell Mol Life Sci       Date:  2015-08-26       Impact factor: 9.261

2.  Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms.

Authors:  Dushani L Palliyaguru; Dionysios V Chartoumpekis; Nobunao Wakabayashi; John J Skoko; Yoko Yagishita; Shivendra V Singh; Thomas W Kensler
Journal:  Free Radic Biol Med       Date:  2016-10-04       Impact factor: 7.376

Review 3.  Chinese nutraceuticals and physical activity; their role in neurodegenerative tauopathies.

Authors:  Abdullahi Alausa; Sunday Ogundepo; Barakat Olaleke; Rofiat Adeyemi; Mercy Olatinwo; Aminat Ismail
Journal:  Chin Med       Date:  2021-01-06       Impact factor: 5.455

4.  Sodium-calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer's disease.

Authors:  Henok Kessete Afewerky; Hao Li; Tongmei Zhang; Xinyan Li; Yacoubou Abdoul Razak Mahaman; Limin Duan; Pengwei Qin; Jiequn Zheng; Lei Pei; Youming Lu
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

5.  Neuroprotective Effect of CR-777, a Glutathione Derivative of Withaferin A, Obtained through the Bioconversion of Withania somnifera (L.) Dunal Extract by the Fungus Beauveria bassiana.

Authors:  Chérif Rabhi; Guillaume Arcile; Géraldine Le Goff; Christian Da Costa Noble; Jamal Ouazzani
Journal:  Molecules       Date:  2019-12-16       Impact factor: 4.411

Review 6.  Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia.

Authors:  Alex B Speers; Kadine A Cabey; Amala Soumyanath; Kirsten M Wright
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.